home about_havidol you_and_havidol resources


Scientific Abstract
Effect of oral dosage of Havidol(R) on blood hedonine levels and longevity: a double-blind placebo-controlled long-term study in a large outpatient population.
Studies by researchers and doctors at The University Medical School(1), have elucidated the mechanism of action of HAVIDOL (avafynetyme HCl). The drug has been shown to bind to receptors for the newly recognized hormone, hedonine, where it acts as a potent agonist. Hedonine has been shown to act on the brain's hedonic center and to induce a feeling of well-being. After administration of Havidol such feelings were greatly enhanced. All patients, even controls who didn't realize they were discontent, improved on Havidol. Furthermore, Havidol also bound to receptors in the heart and reproductive organs, improving general performance and stamina. The drug has a short half life, requiring repeated doses to maintain the beneficial effect appreciated by patients.

(1) This study was funded by a generous grant from Future PHARMS Inc.


Problems can be avoided if you take HAVIDOL only when you are able to immediately benefit from its effects. To fully benefit from HAVIDOL patients are encouraged to engage in activities requiring exceptional mental, motor, and consumptive coordination. HAVIDOL is not for you if you have abruptly stopped using alcohol or sedatives. Havidol should be taken indefinitely. Side effects may include mood changes, muscle strain, extraordinary thinking, dermal gloss, impulsivity induced consumption, excessive salivation, hair growth, markedly delayed sexual climax, inter-species communication, taste perversion, terminal smile, and oral inflammation. Very rarely users may experience a need to change physicians.